ENANTA PHARMACEUTICALS INC's ticker is ENTA and the CUSIP is 29251M106. A total of 173 filers reported holding ENANTA PHARMACEUTICALS INC in Q3 2020. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $362,784 | -73.8% | 32,480 | -49.8% | 0.00% | -100.0% |
| Q2 2023 | $1,385,521 | +53540.0% | 64,744 | +1.4% | 0.00% | -33.3% |
| Q1 2023 | $2,583 | -7.6% | 63,862 | +6.3% | 0.00% | -25.0% |
| Q4 2022 | $2,794 | -99.9% | 60,063 | +0.1% | 0.00% | -20.0% |
| Q3 2022 | $3,112,000 | +18.0% | 60,003 | +7.6% | 0.01% | +25.0% |
| Q2 2022 | $2,637,000 | -31.0% | 55,780 | +3.8% | 0.00% | -20.0% |
| Q1 2022 | $3,824,000 | -5.5% | 53,725 | -0.8% | 0.01% | 0.0% |
| Q4 2021 | $4,048,000 | +29.2% | 54,136 | -1.9% | 0.01% | +25.0% |
| Q3 2021 | $3,134,000 | +14.9% | 55,160 | -11.0% | 0.00% | 0.0% |
| Q2 2021 | $2,727,000 | -16.2% | 61,956 | -6.2% | 0.00% | 0.0% |
| Q1 2021 | $3,256,000 | +18.5% | 66,019 | +1.2% | 0.00% | 0.0% |
| Q4 2020 | $2,747,000 | +0.7% | 65,257 | +9.6% | 0.00% | 0.0% |
| Q3 2020 | $2,727,000 | -11.9% | 59,559 | -3.4% | 0.00% | -20.0% |
| Q2 2020 | $3,095,000 | +3.9% | 61,643 | +6.4% | 0.01% | -16.7% |
| Q1 2020 | $2,979,000 | -10.9% | 57,929 | +7.1% | 0.01% | 0.0% |
| Q4 2019 | $3,343,000 | +9.4% | 54,109 | +6.3% | 0.01% | 0.0% |
| Q3 2019 | $3,057,000 | -27.1% | 50,889 | +2.4% | 0.01% | -25.0% |
| Q2 2019 | $4,192,000 | -6.4% | 49,675 | +5.9% | 0.01% | -11.1% |
| Q1 2019 | $4,480,000 | +35.3% | 46,898 | +0.3% | 0.01% | +28.6% |
| Q4 2018 | $3,312,000 | +1.9% | 46,753 | +22.9% | 0.01% | +16.7% |
| Q3 2018 | $3,250,000 | -25.3% | 38,031 | +1.3% | 0.01% | -33.3% |
| Q2 2018 | $4,352,000 | +45.9% | 37,550 | +1.9% | 0.01% | +50.0% |
| Q1 2018 | $2,982,000 | +39.3% | 36,859 | +1.1% | 0.01% | +50.0% |
| Q4 2017 | $2,140,000 | +42.9% | 36,475 | +14.0% | 0.00% | +33.3% |
| Q3 2017 | $1,498,000 | +33.8% | 31,999 | +2.8% | 0.00% | 0.0% |
| Q2 2017 | $1,120,000 | +16.2% | 31,129 | -0.6% | 0.00% | +50.0% |
| Q1 2017 | $964,000 | +22.3% | 31,305 | +33.1% | 0.00% | 0.0% |
| Q4 2016 | $788,000 | +17.1% | 23,524 | -7.0% | 0.00% | 0.0% |
| Q3 2016 | $673,000 | +25.3% | 25,305 | +4.0% | 0.00% | 0.0% |
| Q2 2016 | $537,000 | -0.4% | 24,340 | +32.5% | 0.00% | 0.0% |
| Q1 2016 | $539,000 | -10.6% | 18,366 | +0.6% | 0.00% | 0.0% |
| Q4 2015 | $603,000 | -0.3% | 18,256 | +9.1% | 0.00% | 0.0% |
| Q3 2015 | $605,000 | -8.2% | 16,731 | +14.2% | 0.00% | 0.0% |
| Q2 2015 | $659,000 | +114.7% | 14,653 | +46.3% | 0.00% | +100.0% |
| Q1 2015 | $307,000 | -26.6% | 10,013 | +21.9% | 0.00% | 0.0% |
| Q4 2014 | $418,000 | +21.9% | 8,213 | -5.2% | 0.00% | 0.0% |
| Q3 2014 | $343,000 | -13.4% | 8,663 | -5.9% | 0.00% | 0.0% |
| Q2 2014 | $396,000 | – | 9,203 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Krensavage Asset Management, LLC | 858,811 | $36,156,000 | 10.56% |
| Fairmount Funds Management LLC | 150,433 | $6,333,000 | 2.26% |
| ARMISTICE CAPITAL, LLC | 1,356,000 | $57,088,000 | 1.94% |
| FARALLON CAPITAL MANAGEMENT LLC | 1,775,000 | $74,728,000 | 0.45% |
| Virtus ETF Advisers LLC | 14,321 | $603,000 | 0.25% |
| Granahan Investment Management | 231,071 | $9,728,000 | 0.22% |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 248,320 | $10,454,000 | 0.09% |
| ACADIAN ASSET MANAGEMENT LLC | 467,514 | $19,684,000 | 0.08% |
| VIRTUS ALTERNATIVE INVESTMENT ADVISERS, INC. | 126 | $5,000 | 0.08% |
| AIGEN INVESTMENT MANAGEMENT, LP | 12,854 | $541,000 | 0.07% |